• Россия
  • Украина

Manufacture: Pfizer Inc.
Country: Canada
Condition: Lymphangioleiomyomatosis, Organ Transplant, Rejection Prophylaxis
Class: Selective immunosuppressants
Form: Tablets, Syrup
Ingredients: sirolimus, phosal 50 pg (ascorbyl palmitate, ethanol, phosphatidyl-choline, propylene glycol, soybean oil fatty acids and sunflower mono and diglycerides), polysorbate 80; calcium sulfate anhydrous, carnauba wax, glyceryl monooleate, lactose monohydrate, magnesium stearate, microcrystalline cellulose, pharmaceutical glaze, polaxamer 188, polyethylene glycol 8000 powdered, polyethylene glycol type 20,000, povidone, vitamin E (dl-alpha tocopherol), sucrose, talc, titanium dioxide and ink. In addition, the 2 mg tablet contains brown #70 iron oxide and yellow #10 iron oxide; the 5 mg tablet contains brown #75 iron oxide, and yellow #10 iron oxide